Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$10.9M Buy
162,127
+93,903
+138% +$6.42M 0.05% 417
2018
Q1
$5.68M Sell
68,224
-21,985
-24% -$1.98M 0.02% 737
2017
Q4
$8.54M Buy
90,209
+26,104
+41% +$2.73M 0.04% 547
2017
Q3
$7.48M Buy
64,105
+19,115
+42% +$2.42M 0.04% 547
2017
Q2
$5.67M Buy
44,990
+32,885
+272% +$4.18M 0.03% 649
2017
Q1
$1.62M Sell
12,105
-13,795
-53% -$1.76M 0.01% 1307
2016
Q4
$2.6M Buy
25,900
+17,674
+215% +$1.72M 0.02% 1114
2016
Q3
$776K Buy
8,226
+5,485
+200% +$462K 0.01% 1991
2016
Q2
$219K Buy
+2,741
New +$213K ﹤0.01% 3080
2016
Q1
Sell
-372
Closed -$27.7K 4688
2015
Q4
$40K Sell
372
-492
-57% -$54.9K ﹤0.01% 4361
2015
Q3
$95K Buy
+864
New +$96.9K ﹤0.01% 4342
2014
Q4
Sell
-40,966
Closed -$2.68M 4872
2014
Q3
$2.01M Buy
+40,966
New +$2.05M 0.02% 1249

Other funds holding INCY

PEAK6 Group's INCY Position: Q2 2018 in Review

PEAK6 Group increased its Incyte (INCY) stake by 138% in Q2 2018, buying an estimated $6.42M and bringing the position to 162,127 shares worth $10.9M. The position accounts for 0.05% of the portfolio, ranked #417.

PEAK6 Group first reported a position in INCY in Q3 2014 and has held it in 12 quarters since. 452 funds tracked by Wall St. Rank hold INCY as of Q2 2018.

  • PEAK6 Group held 162,127 shares of Incyte worth $10.9M as of Q2 2018.
  • PEAK6 Group bought 93,903 Incyte shares in Q2 2018, an estimated $6.42M.
  • Incyte made up 0.05% of PEAK6 Group's portfolio in Q2 2018, its #417 holding.
  • PEAK6 Group first reported a position in Incyte in Q3 2014 and has held it in 12 quarters since.
  • 452 funds tracked by Wall St. Rank held Incyte as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.